The global interbody fusion cage market size was US$ 1992.9 million in 2021. The global interbody fusion cage market size is forecast to reach US$ 3039.1 million by 2030, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2022 to 2030.

The interbody fusion cage is an artificial medical device used during spinal fusion surgeries in order to maintain foraminal height and relieve pressure on spinal canals. The interbody fusion cage consists of a hollow cylinder made of titanium, carbon fiber, or allograft femur. An implant designed as a cage allows a bone graft to be placed inside a hollow cylinder to allow the fusion of two spinal vertebrae. The interbody cage provides stability to the spine and to the cervical region. A cage filled with autologous bone material promotes arthrodesis (artificial induction of joint ossification).

Factors Influencing Market Growth

• The global market is forecast to experience significant growth during the forecast period, driven by a rise in the number of surgeries that require interbody fusion cages due to their advantages of directly decompressing nerves and reconstructing the spine.
• The key factors driving the overall market are the growing geriatric population and the rising number of spinal cord injuries from accidents and diseases like degenerative disk disease. 
• Increasing disposable incomes in emerging economies, high costs associated with spinal fusion surgeries, and a lack of skilled professionals slow down the growth of the interbody fusion cages market.

Impact Analysis of COVID-19

The COVID-19 outbreak had negatively impacted the global interbody fusion cages market growth. The pandemic has impacted outpatient clinics, emergency and elective surgery, rehabilitation, resident training, personnel management, the use of personal protective equipment, and all sub-specialties of orthopedics that perform spinal procedures. As a result of social distancing measures taken by governments globally, hospital and healthcare services substantially declined. Additionally, the COVID-19 pandemic affected the global economy and disrupted the general hospital care system worldwide for patients who did not have the disease. Due to many hospitals and clinics being closed due to the lockdown, demand for interbody fusion cage procedures may decrease for the short term.

Regional Insights

North America led the global interbody fusion cages market in 2021 and is forecast to remain dominant during the forecast period. The increased geriatric population, increased prevalence of spinal disorders, and a rise in the number of sports injuries and fatal accidents are driving the demand for interbody fusion cage devices in North America. Well-established healthcare infrastructure is also forecast to boost the market growth in the region. 

Leading Competitors

The leading prominent companies profiled in the global interbody fusion cages market are:

• Aurora Spine, Incorporated
• B. Braun Melsungen AG
• Benvenue Medical Incorporated
• Prodorth
• Orthofix
• Medtronic Plc.
• Zimmer Biomet Holdings, Incorporated
• NuVasive, Incorporated
• Johnson & Johnson, Incorporated
• Other Prominent Players

Scope of the Report

The global interbody fusion cages market segmentation focuses on Product Type, Surgery, End-User, and Region.

Segmentation based on Product Type

• Lumbar Cage
• Cervical Cage
• Thoraco-lumbar Cage
• Thoracic Cage

Segmentation based on Surgery

• Anterior
• Posterior
• Lateral
• Transforaminal

Segmentation based on End-User

• Hospitals & Clinics
• Ambulatory Surgical Center
• Others

Segmentation based on Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America